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SUMMARY
A retrospective study was conducted to investigate 183
serologically-confirmed cases of dengue fever (DF) admitted
from October 2004 to March 2005 in a large hospital in
Pahang.  Clinical and laboratory features, progress and
outcome of these patients were analysed in order to identify
risk factors associated with development of dengue
haemorrhagic fever (DHF) and dengue shock syndrome
(DSS).  Individually, we found that older patients, secondary
dengue infection, high baseline haematocrit levels, low
platelet levels and prolonged activated partial
thromboplastin time (APTT) ratio were significant
associations with bleeding tendencies.  Of these risk factors,
haematocrit and APTT ratio were two independent
significant risk factors on multivariate analysis.  Older
patients with primary infection and younger patients with
secondary infection had significant bleeding tendencies.  We
also verified the validity of the haematocrit levels suggested
as cut-off levels for plasma leakage for the Malaysian
population by Malaysian Clinical Practice Guidelines for
Dengue Infection in Adults (2003).
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INTRODUCTION
Dengue fever is an endemic infective disease in Malaysia.  It is
an arboviral infection caused by the family Flaviviridae.
Malaysia reported its first case of DF in 1902 and DHF in 1962.
The first major outbreak of dengue haemorrhagic fever (DHF)
in Malaysia occurred in 1973, and the country experienced a
large epidemic with 3005 notified cases with 35 deaths in
19821.  The year 2005 witnessed the highest number of dengue
infection in Malaysia with a significant rise compared to a year
before.  There was a total of 27,659 cases reported in 2005 (till
24th September) with 70 deaths compared to 21,786 cases
reported in 2004, with 68 deaths2.  Pahang had the eighth
highest number of dengue cases reported in 2005 (till
September 2004) after Selangor, Wilayah Persekutuan Kuala
Lumpur, Penang, Johor, Perak, Kedah and Sabah. During that
period, there were 1159 cases of dengue infections reported
from Pahang compared to 412 cases in 20042. 
This study aims to determine risk factors associated with
DHF/DSS in order to help physicians prioritise the
management of high-risk dengue patients.  Efforts made by
previous workers in the same areas include studies by
Narayanan M et al (2002)3, Pancharoen C et al (2002)4,
Shivbalan S et al (2004)5, Wichmann O et al (2004)6 and Diaz-
Quijano FA et al (2005)7.  Most of these studies used univariate
analysis to identify the risk factors. Shibalan et al5 used
multivariate analysis and found platelet of <50,000/mm3,
haemoconcentration and elevated alanine aminotransferase
(ALT) of more than three times that of normal value were risk
factors for DHF. 
MATERIALS AND METHODS
We reviewed all dengue cases admitted to adult medical wards
from October 2004 to March 2005 in Hospital Tengku
Ampuan Afzan (HTAA), Kuantan, Pahang.  Cases with the
discharge diagnosis of either confirmed or suspected DF were
identified from the hospital database. Data regarding clinical
presentations, laboratory investigations and outcome were
analysed. 
Diagnosis of dengue infection is based on World Health
Organization’s (WHO) criteria8 whereby a positive serology
and presence of classical symptoms are essential to make a
confirmed diagnosis. Serology diagnosis of dengue infection
is based on either in-house Enzyme Immunoassay (EIA) or
rapid commercial qualitative immuno-chromatographic tests
manufactured by Panbio (Brisbane, Australia).  The kits used
include Dengue Duo Immunoglobulin M (IgM) and
Immunoglobulin G (IgG) Rapid Strip Test (Cat No. R-
DEN02D), which detects both immunoglobulins on one strip,
IgM Capture ELISA (Cat No. E-DEN01M) and IgG Capture
ELISA (Cat No. E-DEN02G), which detect IgM and IgG
separately.  Positive serology is defined as presence of either
positive IgM or IgG or both.  Equivocal results were excluded
if repeat serology was not available.  Primary infection is
defined as presence of IgM with negative IgG.  Secondary
infection is defined as positive IgG regardless of IgM result as
defined by  Vaughn et al (Thailand, Vietnam)9,10, Chew et al
(Singapore)11 and Lam et al (Malaysia)12.  Patients who had
only IgM performed without IgG were not assigned to either
types of infection.
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“Confirmed Dengue” refers to patients who fulfilled the
WHO criteria of acute dengue infection.  These cases were
included into the analysis of risk factors for DHF/DSS.  “Other
Diagnosis” refers to those with negative serology and/or well-
established alternative clinical diagnosis.  “Indeterminate”
refers to those patients with inconclusive serology and
absence of well-established alternative clinical diagnosis.
“Confirmed Dengue” cases were further classified into two
groups, namely “Classical DF” and “DHF/DSS”.  Definitions
of “Classical DF”, “DHF” and “DSS” are based on WHO
definitions8.
Statistical Analysis
The data was analyzed using SPSS version 13 (Chicago,
Illinois).  Univariate analysis was done for all variables.
Independent sample t-Test or the equivalent non-parametric
Mann-Whitney U Test was used for continuous parameters
depending on their distribution.  Categorical variables were
tested using chi-square test.  Odds ratio (OR) was calculated to
measure the degree of association. Significance was taken at
0.05. 
RESULTS
A total of 358 cases were identified to have discharge
diagnosis of DF/DHF/DSS or ‘Dengue Suspect’.  Out of these
358 cases, 277 (77%) case notes were found and analyzed.
Diagnosis was reviewed for these 277 cases and 183 (66%)
cases fulfilled the criteria for DF/DHF/DSS (Confirmed
Dengue).  Eighty one (29%) cases were identified to be
“Indeterminate” and 13 (5%) cases were found to be “Other
Diagnosis”. The breakdowns for “Confirmed Dengue” cases
are as shown in Figure 1.
From the total of 183 patients with confirmed dengue, there
was almost equal gender distribution with female patients
comprising 52.4%.  The median age of the subjects was 27
years old and 60.0% of the subjects were less than 30 years
old.  There were 148 (80.8%) Malays.
Demographic data between the groups with classical DF and
DHF/DSS, showed that patients aged 30 years and above were
significantly associated with development of DHF/DSS; the
OR was 2.37 (95% CI= 1.14-4.94). However, no significant
association was noted for variables such as gender and race
(Table I).
Analysis of the symptoms and signs with which these patients
presented showed no significant association for variables
such as blood pressure, vomiting, symptoms of upper
respiratory tract infection, abdominal pain, hepatomegaly,
ascites and pleural effusion and development of DHS/DSS.
The only significant symptom associated with DHF/DSS was
diarrhoea; the odd ratio was 2.41 (95% CI = 1.04-5.57) (Table
II).
Laboratory test analysis showed patients with secondary
dengue infections were significantly associated with the
development of DHF/DSS when compared to the group with
primary infection (OR= 2.27; 95% CI= 1.08-4.78).  So was the
group with platelet count less than 35,000/mm3 (OR= 2.73;
95% CI= 1.26-5.89).  On analysing the association of
haematocrit with DHF/DSS, the results showed strong
association of development of DHF/DSS with haematocrit
values of 47% and above for male (OR= 13.22, 95% CI= 3.35-
52.20), and 40% and above for female patients (OR= 3.96,
95% CI =1.52-10.33).  It was also found that haematocrit
fluctuation of more than 20% is highly significant in
association with DHF/DSS, the odd ratio was 39.71 (95% CI=
13.90-113.48).  The group with activated partial
thromboplastin time (APTT) ratio of 1.25 or more was also
found to have significant association with DHF/DSS (OR=
2.82, 95% CI=1.15-6.90), whereas international normalized
ratio (INR) of prothrombin time (PT) was found to have no
significant association with development of DHF/DSS (Table
III).
Only 40 patients in our study population had liver function
tests done during their admission.  Though we were not able
to prove significant association between the liver enzymes
and bleeding tendency, the median aspartate
aminotransferase (AST) was found to be higher in the group
with DHF/DSS as compared to the group with Classical
Dengue (207 IU/l and 119 IU/l respectively).  The same went
for ALT (114 IU/l and 75 IU/l respectively).
High haematocrit (OR=1.15, 95% CI=1.03-1.30) and APTT
ratio of 1.25 and above (OR=2.75, 95% CI=1.06-7.15) were
found to have independent significant association with
DHF/DSS on multivariate analysis (Table IV). 
Stratified analysis between age and types of infection revealed
patients with age of 30 years and above with primary
infection was significantly associated with DHF/DSS (OR
=4.24, 95% CI = 1.40-12.84), on the other hand, age below 30
years with secondary infection was also significantly
associated with DHF/DSS (OR =3.86, 95% CI = 1.29-11.58).
DISCUSSION
The identification of risk factors of DHF/DSS has its
implications for clinical practice. It helps the physicians
prioritize care during an outbreak of dengue infection.
Besides, it offers a clue to the study of the pathogenesis of
dengue infection. 
Effect of age on severity of dengue infection studied by
previous workers showed that infants and young children
were at higher risk of developing DHF/DSS13,14.  Guzman et al
had demonstrated a bipolar pattern of increased mortality,
whereby young infants and the elderly aged 50 years and
older had higher case fatality and hospitalization rates15.  Our
study, being an adult study, showed older age group being
2.37 times more likely to develop DHF/DSS than the younger
age group. 
Secondary infection has been well recognized as the more
aggressive form of dengue infection in the past16,17,
particularly with DEN 2 virus18.  Our data relating severity of
disease with secondary infection (OR 2.27; 95% CI = 1.08-
4.78) are in agreement with previous work.  Wichmann O et
al6 in their study showed that secondary dengue infection was
significantly associated with the development of DHF in
children, but not in adults.  Similarly, our data identified a
significant association between age and types of infection in
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Demographic Characteristics DHF/DSS (n=38) Classical Dengue (n=145) OR (CI 95%)
Age (years)*
>30 21 (29.2%) 51 (70.8%) 2.37 (1.14-4.94)
<30 16 (15.4%) 92 (85.2%)
Gender
Female 25 (26.0%) 71 (74.0%) 0.50 (0.24-1.05)
Male 13 (14.9%) 74 (85.1%)
Race 
Malay 31 (20.9%) 117 (79.1%) 1.06 (0.42-2.65)
Non-Malay 7 (20.0%) 28 (80.0%)
* Age was not known in 3 patients
Table I: Demographic data in subjects with confirmed dengue, comparing those classified as having Classical Dengue and DHF/DSS
Clinical Features DHF/DSS (n=38) Classical Dengue (n=145) OR (CI 95%)
Blood pressure on admission*
Normal 33 (21.2%) 123 (78.8%) 1.88 (0.53-6.68)
Low 3 (12.5%) 21 (87.5%)
(<90/60 mmHg)
Vomiting
Yes 15 (22.4%) 52 (77.6%) 1.17 (0.56-2.43)
No 23 (19.8%) 93 (80.2%)
Diarrhoea
Yes 11 (34.4%) 21 (65.6%) 2.41 (1.04-5.57)
No 27 (17.9%) 124 (82.1%)
URTI symptoms
Yes 6 (21.4%) 22 (78.6%) 1.04 (0.39-2.80)
No 32 (20.6%) 123 (79.4%)
Abdominal pain
Yes 8 (23.5%) 26 (76.5%) 1.22 (0.50-2.97)
No 30 (20.1%) 119 (79.9%)
Hepatomegaly
Yes 12 (26.7%) 33 (73.3%) 1.57 (0.71-3.44)
No 26 (18.8%) 112 (81.2%)
Ascites
Yes 1 (50.0%) 1 (50.0%) 3.89 (0.24-63.70)
No 37 (20.4%) 144 (79.6%)
Pleural effusion
Yes 0 (  0.0%) 3 (100.0%) χ2 p values
No 38 (21.1%) 142 (78.9%)
*There was no initial blood pressure recordings in 3 patients.
Table II: Clinical Features in subjects with confirmed dengue, comparing those classified as having Classical Dengue and DHF/DSS
Laboratory Investigations DHF/DSS (n=38) Classical Dengue (n=145) OR (CI 95%)
IgM and IgG antibodiesa
Secondary Infection 23 (28.4%) 58 (71.6%) 2.27 (1.08-4.78)
Primary Infection 14 (14.9%) 80 (85.1%)
Platelet count on admission
<35, 000/mm3 15 (34.9%) 28 (65.1%) 2.73 (1.26-5.89)
>35, 000/mm3 23 (16.4%) 117 (83.6%)
Haematocrit on admission for maleb
>47% 7 (53.8%) 6 (46.2%) 13.22 (3.35-52.20)
<47% 6  (8.1%) 68 (91.9%)
Haematocrit on admission for femalec
>40% 16 (42.1%) 22 (57.9%) 3.96 (1.52-10.33)
<40% 9 (15.5%) 49 (84.5%)
Haematocrit fluctuation > 20%
Yes 24 (80.0%) 6 (20.0%) 39.71 (13.90-113.48)
No 14 (  9.2%) 139 (90.8%)
Highest APTT ratiod
>1.25 17 (34.7%) 32 (65.3%) 2.82 (1.15-6.90)
<1.25 10 (15.9%) 53 (84.1%)
Highest INR, mediand 0.955 0.910 t-value
a  There were 8 undetermined cases whereby IgG was not performed. N=175.
b  N=87
c  N=96
d Only 112 patients had coagulation profile performed on admission, N=112.
Table III: Laboratory investigations in subjects with confirmed dengue, comparing those classified as 
having Classical Dengue and DHF/DSS
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Risk factors Odds ratio (95% CI) p value
Age 1.80 (0.67-4.83) 0.25
Secondary Infection 0.70 (0.25-1.94) 0.50
Haematocrit on admission 1.15 (1.03-1.30) 0.02
Platelet on admission 1.00 (0.99-1.01) 0.53
APTT ratio 2.75 (1.06-7.15) 0.04
Table IV: Multivariate analysis of univariately significant risk factors for DHF/DSS
relation to development of DHF/DSS.  Our study revealed
secondary infection was actually more severe in patients with
age below 30 years (OR=3.86, 95% CI=1.29-11.58).  For
patients age 30 years and above, it was primary infection that
was more severe (OR= 4.24, 95% CI= 1.40-12.84).
Haematocrit has been used as an important parameter in
monitoring patients with dengue infection.  There were
previous studies identifying cut-off values for the local
population in defining DHF.  Cao XT et al in 2004 found the
median haematocrit value for DHF in Vietnamese children
being 48%19.   Gomber S et al in 2001 defined the haematocrit
value diagnostic of DHF in Indian children at 36.3%, with
sensitivity and specificity of 60% and 94%20 respectively.  In
our study we concur with Malaysia’s Clinical Practice
Guidelines for Dengue Infections in Adults21, in which
haematocrit values of 47% for male and 40% for female were
suggested for cut-off value to suspect plasma leakage.  In our
study, we had validated that these values are useful to
determine risk of DHF/DSS.  We also found that a fluctuation
of 20% in the haematocrit values has highly significant
association with DHF/DSS (OR= 39.71).  However, clinical
usefulness may be limited by the duration needed to observe
the drop in haematocrit of more than 20%.
Dengue infection causes deranged coagulation profile in
which the APTT is affected more that the PT22,23. Chua MN et
al advocated APTT of >30 seconds to be used as an index in
predicting bleeding in DHF24. Increased PTT and
hypofibrinogenemia are a result of stimulation of intrinsic
coagulation pathway probably from immunologic reaction.
Although no significant decrease in coagulation factors were
recorded23, high level of von Willebrand factor was noted in
DHF, especially during the early phase of the disease25.  In our
Fig. 1: Schematic diagram showing the final disease classification for all patients enrolled in the study
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study, we demonstrated significant association of prolonged
APTT with the development of DHF/DSS (OR= 2.82, 95%
CI=1.15-6.90), in agreement with other published studies. 
The authors strongly felt that raised liver enzymes, especially
aspartate aminotransferase (AST) may be a significant risk
factor for DHF/DSS, as demonstrated by many studies in the
past23,26.  However, in our study, there were only 40 patients
with confirmed dengue had liver function tests.  The analysis
of these limited data revealed the group with DHF/DSS had
higher median ALT and AST.  However these results were not
statistically significant.
We were also not able to conclude that the risk factors for
DHF/DSS studied could be extrapolated to predict mortality,
as the number of mortality in the study period was too small
(3 deaths out of 183 confirmed dengue).  Additional studies
with larger cohorts will be necessary to further investigate the
associations between these risk factors and mortality.
CONCLUSION
Haematocrit, APTT ratio, secondary dengue infection in age
below 30 years old and primary dengue infection in age 30
years old and above are significant risk factors in predicting
occurrence of DHF/DSS. These factors could be utilized to
formulate a predicting score to identify potential DHF/DSS in
future outbreaks in order to prioritize care and reduce
mortality.
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